
Regulatory compliance - June 30, 2013
EU fines drug firms for delaying generics
The EU commission has filed Danish Lundbeck and eight other pharmaceutical firms for paying off rivals to delay production of generics. Photo. European Commissioner for Competition Joaquin Almunia during a press conference. The EU commission reached a decision in the several years’ long trial on Danish pharmaceutical firm Lundbeck for blocking generic versions of antidepressant drug […]